Jiangsu Lianhuan Pharmaceutical Co., Ltd.
600513
Rank in Stocks
#11571
Jiangsu Lianhuan Pharmaceutical Co., Ltd. operates within China, specializing... Jiangsu Lianhuan Pharmaceutical Co., Ltd. operates within China, specializing in the production and distribution of chemical raw materials, pharmaceutical formulations, and organic intermediate compounds. Its extensive product range addresses diverse therapeutic needs, including cardiovascular issues, allergies, urinary tract conditions, infectious diseases, and immune system modulation. The enterprise was founded in 2000 and has its principal headquarters located in Yangzhou, China.
Share Price
$1.93
Last synced: 2026-11-10
Market Cap
$552.28M
Change (1 day)
0.55%
Change (1 year)
-41.22%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Jiangsu Lianhuan Pharmaceutical Co., Ltd. (600513)
Category
Healthcare
Operating Margin for Jiangsu Lianhuan Pharmaceutical Co., Ltd. (600513)
Operating Margin as of November 2026 TTM: -0.96%
According to Jiangsu Lianhuan Pharmaceutical Co., Ltd.'s latest financial reports, its current operating margin (TTM) is -0.96%. At the end of 2025 the company had an operating margin of -0.38%.
Operating Margin history for Jiangsu Lianhuan Pharmaceutical Co., Ltd. from 2000 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -0.96% | 152.63% |
| 2025 | -0.38% | -106.27% |
| 2024 | 6.06% | -24.63% |
| 2023 | 8.04% | -15.99% |
| 2022 | 9.57% | 0.84% |
| 2021 | 9.49% | -8.13% |
| 2020 | 10.33% | 30.93% |
| 2019 | 7.89% | -9.21% |
| 2018 | 8.69% | -33.77% |
| 2017 | 13.12% | 3.55% |
| 2016 | 12.67% | 38.17% |
| 2015 | 9.17% | 14.20% |
| 2014 | 8.03% | 7.35% |
| 2013 | 7.48% | -7.31% |
| 2012 | 8.07% | -11.03% |
| 2011 | 9.07% | 9.67% |
| 2010 | 8.27% | 11.31% |
| 2009 | 7.43% | 38.88% |
| 2008 | 5.35% | 29.23% |
| 2007 | 4.14% | -50.06% |
| 2006 | 8.29% | 19.28% |
| 2005 | 6.95% | -2.80% |
| 2004 | 7.15% | -56.64% |
| 2003 | 16.49% | -46.43% |
| 2002 | 30.78% | 3.81% |
| 2001 | 29.65% | 26.17% |
| 2000 | 23.50% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 19.41% | -120.22% |
DE
|
|
| 19.68% | -120.50% |
DE
|
|
| 13.26% | -113.81% |
JP
|
|
| 17.08% | -117.79% |
CH
|
|
| 14.92% | -115.54% |
IL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Jiangsu Lianhuan Pharmaceutical Co., Ltd.'s operating margin
What is Jiangsu Lianhuan Pharmaceutical Co., Ltd.'s operating margin?
Jiangsu Lianhuan Pharmaceutical Co., Ltd.'s operating margin is -0.96%, as of Nov 2026.
What was Jiangsu Lianhuan Pharmaceutical Co., Ltd.'s operating margin in 2025?
In 2025, Jiangsu Lianhuan Pharmaceutical Co., Ltd.'s operating margin was -0.38%, compared with 6.06% in 2024.
How has Jiangsu Lianhuan Pharmaceutical Co., Ltd.'s operating margin changed since 2020?
From 2020 to 2025, Jiangsu Lianhuan Pharmaceutical Co., Ltd.'s operating margin was highest in 2020 (10.33%) and lowest in 2025 (-0.38%).
How does Jiangsu Lianhuan Pharmaceutical Co., Ltd.'s operating margin compare with similar companies?
Jiangsu Lianhuan Pharmaceutical Co., Ltd.'s operating margin (-0.96%) is lower than that of all 5 similar companies listed above. The highest among them is Merck KGaA, with 19.68%.